These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 9103852

  • 1. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension].
    Tabata T, Ono S, Song C, Noda M, Suzuki S, Tanita T, Fujimura S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):160-6. PubMed ID: 9103852
    [Abstract] [Full Text] [Related]

  • 2. [Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)].
    Ono S, Tanita T, Ashino Y, Noda M, Tabata S, Hoshikawa Y, Ueda S, Nishimura T, Fujimura S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May; 32(5):441-5. PubMed ID: 8084100
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension.
    Broderick TL, King TM.
    Med Sci Monit; 2008 Dec; 14(12):BR261-4. PubMed ID: 19043358
    [Abstract] [Full Text] [Related]

  • 4. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J, Shimpo H, Shimamoto A, Chong AJ, Hampton CR, Spring DJ, Yada M, Takao M, Onoda K, Yada I, Pohlman TH, Verrier ED.
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [Abstract] [Full Text] [Related]

  • 5. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension].
    Ono S, Tanita T, Hoshikawa Y, Song C, Maeda S, Tabata T, Noda M, Ueda S, Ashino Y, Fujimura S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567
    [Abstract] [Full Text] [Related]

  • 6. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G.
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [Abstract] [Full Text] [Related]

  • 7. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL, Germain S, Embury J, Gannon KS, Jacques V, Murray J, Byrne BJ, Shacham S, Al-Mousily F.
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [Abstract] [Full Text] [Related]

  • 8. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y.
    Respiration; 2006 Aug; 73(1):105-12. PubMed ID: 16432296
    [Abstract] [Full Text] [Related]

  • 9. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B, Cheng YS, Dai DZ, Li N, Zhang TT, Dai Y.
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [Abstract] [Full Text] [Related]

  • 10. Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in rats.
    Jin HF, Du SX, Zhao X, Wei HL, Wang YF, Liang YF, Tang CS, Du JB.
    Acta Pharmacol Sin; 2008 Oct; 29(10):1157-66. PubMed ID: 18817619
    [Abstract] [Full Text] [Related]

  • 11. [Expression of GATA6 gene in lung tissue of rat with pulmonary hypertension].
    Liu B, Liu HM, Yu L, Sun XJ, Wei L, Wang XM, Zhou TF.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):864-7, 875. PubMed ID: 17236581
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
    Cassis LA, Rippetoe PE, Soltis EE, Painter DJ, Fitz R, Gillespie MN.
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1168-72. PubMed ID: 1527721
    [Abstract] [Full Text] [Related]

  • 13. Suppressive effect of pulmonary hypertension and leukocyte activation by inhaled prostaglandin E1 in rats with monocrotaline-induced pulmonary hypertension.
    Kato S, Sugimura H, Kishiro I, Machida M, Suzuki H, Kaneko N.
    Exp Lung Res; 2002 Jun; 28(4):265-73. PubMed ID: 12042029
    [Abstract] [Full Text] [Related]

  • 14. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M, Hasegawa Y, Tanida I, Nakagawa E, Inaji H, Ohkita M, Matsumura Y.
    Eur J Pharmacol; 2009 Jul 01; 614(1-3):70-6. PubMed ID: 19379725
    [Abstract] [Full Text] [Related]

  • 15. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D, Reid LM.
    Lab Invest; 1985 Mar 01; 52(3):298-303. PubMed ID: 3156262
    [Abstract] [Full Text] [Related]

  • 16. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats].
    Kakusaka I, Kaneko N, Kiyatake K, Fujita A, Suzuki A, Nakano K, Okada O, Sugita T, Watanabe S, Kuriyama T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan 01; 27(1):51-6. PubMed ID: 2501548
    [Abstract] [Full Text] [Related]

  • 17. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
    Pan LC, Wilson DW, Lamé MW, Jones AD, Segall HJ.
    Toxicol Appl Pharmacol; 1993 Jan 01; 118(1):87-97. PubMed ID: 8430429
    [Abstract] [Full Text] [Related]

  • 18. [Role of peptide leukotrienes in monocrotaline-induced lung disease].
    Ono S, Noda M, Tanita T, Hoshikawa Y, Tabata T, Ueda S, Nishimura T, Ashino Y, Koike K, Fujimura S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec 01; 33(12):1415-1420. PubMed ID: 8821996
    [Abstract] [Full Text] [Related]

  • 19. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
    Yip HK, Chang LT, Sun CK, Sheu JJ, Chiang CH, Youssef AA, Lee FY, Wu CJ, Fu M.
    Crit Care Med; 2008 Mar 01; 36(3):873-80. PubMed ID: 18431275
    [Abstract] [Full Text] [Related]

  • 20. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
    Mathew R, Zeballos GA, Tun H, Gewitz MH.
    Cardiovasc Res; 1995 Nov 01; 30(5):739-46. PubMed ID: 8595621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.